Could Co-Founder Rush-Register A Planning Trademark As His Own?

lehmanbrown

 (By Luo Yanjie) Article 15 of both the 2014 version and the 2001 version of the Trademark Law stipulated that an agent shall not rush-register trademarks of the principal or the represented. In practice, Article 15 is always used to prevent from rush-registration. The following judgment will introduce a typical rush-registration case with new ideas for reference.

 Introduction to the Case:

Re-appellant (plaintiff at first instance, appellant at second instance): LEHMANBROWN LIMITED (the “HK Company”)

READ MORE

Why Did the Court Not Rule in Accordance With Article 14 of the Anti Monopoly Law? Part II

(By You Yunting) August 1, 2013 was the fifth anniversary of the enactment of China’s AntiMonopoly Law. On the same day, Shanghai Higher People’s Courts handed down the first decision that supported a plaintiff’s claim in an anti-monopoly civil ligation in China. The court determined that Johnson & Johnson Medical Co. Ltd action constituted as a vertical monopoly for restricting the minimum sales price, and the company was ordered to make civil compensation for the plaintiff’s loss.

READ MORE

Why Did the Court Not Rule in Accordance With Article 14 of the Anti Monopoly Law? Part I

(By You Yunting) August 1, 2013 was the fifth anniversary of the enactment of China’s AntiMonopoly Law. On the same day, Shanghai Higher People’s Courts handed down the first decision that supported a plaintiff’s claim in an anti-monopoly civil ligation in China. The court determined that Johnson & Johnson Medical Co. Ltd action constituted as a vertical monopoly for restricting the minimum sales price, and the company was ordered to make civil compensation for the plaintiff’s loss.

READ MORE

Plaintiff First Wins Chinese Anti Monopoly Civil Case

图片1

(By You Yunting) The fifth anniversary of enforcement of Chinese Anti Monopoly Law fell on August 1, 2008. Just on this day, Shanghai Higher People’s Courts first supported plaintiff’s claim in anti-monopoly civil case. The court determined that Johnson & Johnson Medical Co. Ltd constitutes a vertical monopoly for restricting on the minimum sales price and shall make civil compensation on plaintiff’s loss.   Past essays on this website have introduced the first instance judgment on this case made by Shanghai No.2 Intermediate Court; the summary of the judgment is as followed: Do All Minimum Price Limits Violate the Anti-trust Law in China?   The plaintiff, Beijing Rui Bang Yong He Science and Trading Co., Ltd. (the “plaintiff”) used to be the dealer of Johnson & Johnson Medical (Shanghai) Ltd. and Johnson & Johnson Medical (China) Ltd. (the “defendants”). Cooperation between the parties lasted for nearly fifteen years, and the distribution contract was renewed each year. On January 2, 2008, the defendants entered into a distribution contract with the plaintiff stipulating that the plaintiff could not sell the product below the price set by the defendants.   On July 1, 2008, the defendants sent a letter to the plaintiff, saying that they would deduct the RMB 20,000 yuan deposit paid by the plaintiff due to the plaintiff’s unlicensed markdown sale. In the meantime, the defendants ordered plaintiff to stop its lower priced sales and stated that the plaintiff’s product supply would be cancelled and that the plaintiff would no longer be the defendants’ dealer.   The plaintiff believed that the defendants’ limit on the minimum sales price has constituted the floor price setting as prohibited in Paragraph 2 of Article 14 in the Anti Monopoly Law, and thereby caused damages to the plaintiff. Basing on these, the plaintiff filed a lawsuit in the court, claiming the compensation.   After the hearing, the Shanghai No.1 Intermediate People’s Court held that the decision on the existence of monopoly agreements as regulated by Article 14 of the Anti Monopoly Law could not only consider whether the undertakings have concluded a monopoly agreement with their trading counterparts that would fix or limit sales prices, but also consider Paragraph 2 of Article 13. This means it is necessary to further check whether the agreement excludes or limits competition. Considering the evidence presented by the plaintiff could not prove the above issues, the court refused all the claims of the plaintiff.   Shanghai Higher Court held after the trial that Anti Monopoly Law shall be applied in the case, since the distribution contract between the plaintiff and the defendants containing clauses restricting the plaintiff to sell the product at a minimum price constitutes such effects of eliminating or restricting competition without clearly sufficient promotion for competition. For these reasons, the higher court determined the distribution contract constituted a monopoly agreement as regulated by Article 14 of the Anti Monopoly Law. Concerning the fact that the defendant took such actions that could be involved in the monopoly as provided in the Anti Monopoly Law, the court determined that those actions concluded a monopoly agreement prohibited by the Anti Monopoly Law and accordingly the defendant shall make compensation for loss to the plaintiff. On these grounds, the higher court reversed the original judgment and decided that the defendant shall make compensation in the amount of RMB 530, 000 yuan to the plaintiff in 10 days. In addition, the higher court refused the other claims made by the plaintiff.   Our lawyers have already obtained the second instance judgment. We would interpret it in the next week’s post.

READ MORE

Could Apple Use Objection to Jurisdiction to Prolong the Litigation Period?

By Albert Chen

The most watched copyright battle between Chinese Writer Alliance (the “Alliance”) and Apple was heard in Beijing No.2 Intermediate People’s Court on the 11th of this month. You may have read our previous essay on the private hearing of the case, and in fact, Apple has also filed an objection to the jurisdiction in the case. Nonetheless, the application was refused by the intermediate court and upheld by the high court after appeal. The lawsuit has been delayed by procedure for nearly half a year, as favored by Apple. Today, we are going to introduce the regulation on the objection to civil jurisdiction in China.

READ MORE

Has Apple Lost Opportunity of In-Camera Hearing on Its Case?

By Albert Chen

The most watched dispute between Baidu (NASDAQ: BIDU) and Chinese Writers Alliance (the “Alliance”) is heard on 11th of October in Beijing No.2 Intermediate People’s Court. That lawsuit is filed following the battle against Baidu by the Alliance. Before the hearing on 11th, Apple applied to the court for the hearing in camera with the claim that the case is with trade secret related. After the consideration by the court, such an application was refused by the judge, yet it still decided the procedure may switch into be in private when one the interrogation involves the business secret. In today’s post, you may see our analysis on the “lawsuit in camera” in China.

READ MORE